Novavax, Inc. NVAX
Set alert
9.53 USD -0.55 -5.46%
At close · Nov 2
9.60 +0.07 +0.73%
After hours · Nov 2, 6:20 PM ET
9.49 Day range 10.38
6.20 52-week range 13.39
- YTD
- +41.82%
- 1 year
- +13.45%
- Open
- 10.11
- Prev close
- 10.08
- Mkt cap
- 1.57B
- Vol
- 4.09M
- Avg vol
- 6.33M
- EPS
- -1.49
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.49
- High
- 10.38
- Forward P/E
- -58.14
- Beta
- 2.72
- Short ratio
- 5.77
- Inst. own
- 66.64%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 10.46
- 200-d avg
- 9.29
- 1y target
- 14.44
MAX chart
Events in this range
- Aug 6, 2025Earnings: 0.62; estimate -0.07; surprise 985.71%
- Nov 6, 2025Earnings: -1.25; estimate -1.08; surprise -15.74%
- May 6, 2026Earnings: -0.06; estimate -0.25; surprise 76%
- May 6, 2026Rating: TD Cowen · Hold → Hold
- Aug 6, 2026Earnings: -0.32; estimate -0.37984; surprise 15.75%
- Nov 5, 2026Earnings: —; estimate -0.34595; surprise —%
Signals (122)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| SMA: Bullish | Jan 1, 2026 | 10 months ago |
| SMA: Bearish | Nov 1, 2025 | 1 year ago |
| SMA: Bearish | Nov 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Nov 1, 2024 | 2 years ago |
| SMA: Bullish | May 1, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 1, 2023 | 3 years ago |
| SMA: Bearish | Jan 1, 2022 | 4 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| SMA: Bullish | Nov 1, 2021 | 5 years ago |
Newest 20 of 122.
Financial health
Altman Z-Score
-5.75 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E 2.5×
FY 2016 5y median -1.2× FY 2025
P/S 1.0×
FY 2016 5y median 1.0× FY 2025
P/B -8.5×
FY 2016 5y median -2.0× FY 2025
P/FCF -4.4×
FY 2016 5y median -1.6× FY 2025
EV/EBITDA 2.2×
FY 2016 5y median -0.3× FY 2025
EV/Sales 1.0×
FY 2016 5y median 1.0× FY 2025
FCF Yield -23.0%
FY 2016 5y median -23.0% FY 2025
Profitability
Gross Margin 93.7%
FY 2016 5y median 70.3% FY 2025
Operating Margin 50.1%
FY 2016 5y median -40.3% FY 2025
Net Margin 39.2%
FY 2016 5y median -41.1% FY 2025
ROE -344.7%
FY 2016 5y median 76.0% FY 2025
ROIC 78.0%
FY 2016 5y median -338.2% FY 2025
ROA 37.4%
FY 2016 5y median -29.1% FY 2025
Growth (YoY)
Revenue 64.7%
FY 2016 FY 2025
Operating Income 326.3%
FY 2016 FY 2025
EPS (diluted) 306.5%
FY 2016 FY 2025
Free Cash Flow -149.4%
FY 2016 FY 2025
Financial Health
Current Ratio 2.1×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 2.1×
FY 2016 5y median 0.9× FY 2025
Debt / Equity -1.9×
FY 2016 5y median -0.9× FY 2025
Net Debt / EBITDA 0.0×
FY 2016 5y median 0.7× FY 2025
Interest Coverage 25.0×
FY 2016 5y median -32.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
